Convalescent plasma to treat COVID-19: clinical experience and efficacy

被引：0
作者：
Pei, Shiyao [1 ,2 ]
Yuan, Xi [3 ]
Zhang, Zhimin [3 ]
Yao, Run [3 ]
Xie, Yubin [4 ]
Shen, Minxue [2 ]
Li, Bijuan [3 ]
Chen, Xiang [1 ,2 ]
Yin, Mingzhu [1 ,2 ]
机构：
[1] Cent South Univ, Xiangya Hosp, Hunan Engn Res Ctr Obstet & Gynecol Dis, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Hunan Engn Res Ctr Skin Heath & Dis, Dept Dermatol, Changsha 410008, Hunan, Peoples R China
[3] Cent South Univ, Dept Blood Transfus Xiangya Hosp, Changsha 410008, Hunan, Peoples R China
[4] Changsha Blood Ctr, Dept Blood Transfus Lab, Changsha 410008, Hunan, Peoples R China
来源：
AGING-US | 2021年 / 13卷 / 06期
关键词：
COVID-19; convalescent plasma;
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The recent outbreak of COVID-19 in the world is currently a big threat to global health and economy. Convalescent plasma has been confirmed effective against the novel corona virus in preliminary studies. In this paper, we first described the therapeutic schedule, antibody detection method, indications, contraindications of the convalescent plasmas and reported the effectiveness of convalescent plasma therapy by a retrospective cohort study.
引用
收藏
页码：7758 / 7766
页数：9
相关论文
共 8 条
  • [1] [Anonymous], CLIN TREATMENT COVID
  • [2] COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease
    Chan, Kam Wa
    Wong, Vivian Taam
    Tang, Sydney Chi Wai
    [J]. AMERICAN JOURNAL OF CHINESE MEDICINE, 2020, 48 (03): : 737 - 762
  • [3] Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
    Chen, Nanshan
    Zhou, Min
    Dong, Xuan
    Qu, Jieming
    Gong, Fengyun
    Han, Yang
    Qiu, Yang
    Wang, Jingli
    Liu, Ying
    Wei, Yuan
    Xia, Jia'an
    Yu, Ting
    Zhang, Xinxin
    Zhang, Li
    [J]. LANCET, 2020, 395 (10223) : 507 - 513
  • [4] FDA, FDA BRIEF DOC CARD R
  • [5] Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
    Hung, Ivan F. N.
    To, Kelvin K. W.
    Lee, Cheuk-Kwong
    Lee, Kar-Lung
    Chan, Kenny
    Yan, Wing-Wah
    Liu, Raymond
    Watt, Chi-Leung
    Chan, Wai-Ming
    Lai, Kang-Yiu
    Koo, Chi-Kwan
    Buckley, Tom
    Chow, Fu-Loi
    Wong, Kwan-Keung
    Chan, Hok-Sum
    Ching, Chi-Keung
    Tang, Bone S. F.
    Lau, Candy C. Y.
    Li, Iris W. S.
    Liu, Shao-Haei
    Chan, Kwok-Hung
    Lin, Che-Kit
    Yuen, Kwok-Yung
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (04) : 447 - 456
  • [6] Convalescent Plasma to Treat COVID-19 Possibilities and Challenges
    Roback, John D.
    Guarner, Jeannette
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16): : 1561 - 1562
  • [7] Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
    Soo, YOY
    Cheng, Y
    Wong, R
    Hui, DS
    Lee, CK
    Tsang, KKS
    Ng, MHL
    Chan, P
    Cheng, G
    Sung, JJY
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (07) : 676 - 678
  • [8] WHO, 2020, COR DIS 2019 COVID 1
1